Patent assignee · US · COMPANY

Lycera Corporation

36Patents
36Active
36Granted
56Portfolio score

Filing activity: Nov 8, 2011 → Feb 14, 2019

Most-cited patents

PatentTitleAreaCited byStatus
US9266827B2 Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 22 Active
US9512111B2 N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Chemistry; Metallurgy 21 Active
US9657033B2 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Chemistry; Metallurgy 19 Active
US9394315B2 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 14 Active
US9663502B2 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 12 Active
US9000014B2 Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 12 Active
US9783511B2 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 9 Active
US9169199B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 8 Active
US9809561B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 8 Active
US9139532B2 Pyrazolyl guanidine F1F0-atpase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 8 Active
US9370507B2 Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 8 Active
US9221814B2 Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 8 Active
US9266839B2 Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Human Necessities 8 Active
US9802958B2 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease Chemistry; Metallurgy 7 Active
US10208061B2 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 6 Active
US9896441B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 6 Active
US10221146B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 6 Active
US10377768B2 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 5 Active
US9580391B2 Saturated acyl guanidine for inhibition of F1F0-ATPase Chemistry; Metallurgy 4 Active
US9707211B2 Trifluoromethyl pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Human Necessities 4 Active
US9580388B2 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Chemistry; Metallurgy 4 Active
US10421751B2 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US10364237B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US10189777B2 Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active
US10442798B2 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.